Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9603)
All Articles published online
|
Publishing Process of This Article
|
Feb 28, 2016 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Charrez B, Qiao L, Hebbard L. Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play. World J Gastroenterol 2016; 22(8): 2494-2502 [PMID: 26937137 DOI: 10.3748/wjg.v22.i8.2494] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i8/2494.htm |
| Number | Citing Articles |
| 1 |
Derek B. Allison, David Borzik, Qing Kay Li. Atlas of Non-Gynecologic Cytology. 2018; : 173 doi: 10.1007/978-3-319-89674-8_7
|
| 2 |
Juan Jovel, Zhen Lin, Sandra O'keefe, Steven Willows, Weiwei Wang, Guangzhi Zhang, Jordan Patterson, Carlos Moctezuma‐Velázquez, David J. Kelvin, Gane Ka‐Shu Wong, Andrew L. Mason. A Survey of Molecular Heterogeneity in Hepatocellular Carcinoma. Hepatology Communications 2018; 2(8): 945 doi: 10.1002/hep4.1197
|
| 3 |
Divya P. Kumar, Prasanna K. Santhekadur, Mulugeta Seneshaw, Faridoddin Mirshahi, Cora Uram‐Tuculescu, Arun J. Sanyal. A Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma. Hepatology 2019; 69(4): 1520 doi: 10.1002/hep.30346
|
| 4 |
Osmanuddin Ahmed, Lisa Liu, Antony Gayed, Amanjit Baadh, Mikin Patel, Jordan Tasse, Ulku Turba, Bulent Arslan. The Changing Face of Hepatocellular Carcinoma: Forecasting Prevalence of Nonalcoholic Steatohepatitis and Hepatitis C Cirrhosis. Journal of Clinical and Experimental Hepatology 2019; 9(1): 50 doi: 10.1016/j.jceh.2018.02.006
|
| 5 |
Zhi Zhang, Huiqing Wen, Bangjian Peng, Jun Weng, Fanhong Zeng. Downregulated microRNA-129-5p by Long Non-coding RNA NEAT1 Upregulates PEG3 Expression to Aggravate Non-alcoholic Steatohepatitis. Frontiers in Genetics 2021; 11 doi: 10.3389/fgene.2020.563265
|
| 6 |
Yue Jia, Ping Ji, Barbara French, Brittany Tillman, Samuel W. French. The different expression of tumor suppressors, RASSF1A, RUNX3, and GSTP1, in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH). Experimental and Molecular Pathology 2019; 108: 156 doi: 10.1016/j.yexmp.2019.04.002
|
| 7 |
Priyankar Dey, Joshua B. Kim, Chureeporn Chitchumroonchokchai, Jinhui Li, Geoffrey Y. Sasaki, Bryan D. Olmstead, Katie L. Stock, Jennifer M. Thomas-Ahner, Steven K. Clinton, Richard S. Bruno. Green tea extract inhibits early oncogenic responses in mice with nonalcoholic steatohepatitis. Food & Function 2019; 10(10): 6351 doi: 10.1039/C9FO01199D
|
| 8 |
Somdat Mahabir. Is nonalcoholic fatty liver disease driving the increased incidence of liver cancer?. Cancer 2016; 122(14): 2277 doi: 10.1002/cncr.30055
|
| 9 |
Katherine J. P. Schwenger, Sandra E. Fischer, Timothy D. Jackson, Allan Okrainec, Johane P. Allard. Non-alcoholic Fatty Liver Disease in Morbidly Obese Individuals Undergoing Bariatric Surgery: Prevalence and Effect of the Pre-Bariatric Very Low Calorie Diet. Obesity Surgery 2018; 28(4): 1109 doi: 10.1007/s11695-017-2980-3
|
| 10 |
Melisa Kozaczek, Walter Bottje, Byungwhi Kong, Diyana Albataineh, Reza Hakkak. A Comparison of Short- and Long-Term Soy Protein Isolate Intake and Its Ability to Reduce Liver Steatosis in Obese Zucker Rats Through Modifications of Genes Involved in Inflammation and Lipid Transport. Journal of Medicinal Food 2021; 24(9): 1010 doi: 10.1089/jmf.2020.0180
|
| 11 |
Yongrong Liao, Izabela Sumara, Evanthia Pangou. Non-proteolytic ubiquitylation in cellular signaling and human disease. Communications Biology 2022; 5(1) doi: 10.1038/s42003-022-03060-1
|
| 12 |
Ilkay S. Idilman, Ilknur Ozdeniz, Musturay Karcaaltincaba. Hepatic Steatosis: Etiology, Patterns, and Quantification. Seminars in Ultrasound, CT and MRI 2016; 37(6): 501 doi: 10.1053/j.sult.2016.08.003
|
| 13 |
Dzeina Mezale, Ilze Strumfa, Andrejs Vanags, Matiss Mezals, Ilze Fridrihsone, Boriss Strumfs, Dainis Balodis. Liver Cirrhosis - Update and Current Challenges. 2017; doi: 10.5772/intechopen.68771
|
| 14 |
Ali Zarrinpar. Metabolic Pathway Inhibition in Liver Cancer. SLAS Technology 2017; 22(3): 237 doi: 10.1177/2472630317698683
|
| 15 |
Yanping Zhao, Lei Ye, Yaping Yu. MicroRNA-126-5p suppresses cell proliferation, invasion and migration by targeting EGFR in liver cancer. Clinics and Research in Hepatology and Gastroenterology 2020; 44(6): 865 doi: 10.1016/j.clinre.2020.03.025
|
| 16 |
Xinwei Yang, Zhiquan Qiu, Rongzhen Ran, Longjiu Cui, Xiangji Luo, Mengchao Wu, Wei‑Feng Tan, Xiaoqing Jiang. Prognostic importance of bile duct invasion in surgical resection with curative intent for hepatocellular carcinoma using PSM analysis. Oncology Letters 2018; doi: 10.3892/ol.2018.9108
|
| 17 |
Kun Zhu, Yi Tang, Xuan Xu, Hien Dang, Liu-Ya Tang, Xiang Wang, Xin Wei Wang, Ying E. Zhang, Brian Finck. Non-proteolytic ubiquitin modification of PPARγ by Smurf1 protects the liver from steatosis. PLOS Biology 2018; 16(12): e3000091 doi: 10.1371/journal.pbio.3000091
|
| 18 |
Takaaki Izumi, Takuya Sho, Kenichi Morikawa, Taku Shigesawa, Kazuharu Suzuki, Akihisa Nakamura, Masatsugu Ohara, Naoki Kawagishi, Machiko Umemura, Tomoe Shimazaki, Megumi Kimura, Masato Nakai, Goki Suda, Mitsuteru Natsuizaka, Koji Ogawa, Yusuke Kudo, Mutsumi Nishida, Kota Ono, Masaru Baba, Ken Furuya, Naoya Sakamoto. Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter. Hepatology Research 2019; 49(10): 1207 doi: 10.1111/hepr.13391
|
| 19 |
Shinichi Umeda, Mitsuro Kanda, Hiroyuki Sugimoto, Haruyoshi Tanaka, Masamichi Hayashi, Suguru Yamada, Tsutomu Fujii, Hideki Takami, Yukiko Niwa, Naoki Iwata, Chie Tanaka, Daisuke Kobayashi, Michitaka Fujiwara, Yasuhiro Kodera. Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3629-2
|
| 20 |
Daniel Neureiter, Sebastian Stintzing, Tobias Kiesslich, Matthias Ocker. Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets. World Journal of Gastroenterology 2019; 25(25): 3136-3150 doi: 10.3748/wjg.v25.i25.3136
|
| 21 |
George Cholankeril, Ronak Patel, Sandeep Khurana, Sanjaya K Satapathy. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management. World Journal of Hepatology 2017; 9(11): 533-543 doi: 10.4254/wjh.v9.i11.533
|
| 22 |
Xiaoyu Wang, Michael Hausding, Shih-Yen Weng, Yong Ook Kim, Sebastian Steven, Thomas Klein, Andreas Daiber, Detlef Schuppan. Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis. Antioxidants & Redox Signaling 2018; 28(2): 87 doi: 10.1089/ars.2016.6953
|
| 23 |
Nathalia Soares da Cruz, Gabriel Pasquarelli-do-Nascimento, Augusto Cézar Polveiro e Oliveira, Kelly Grace Magalhães. Inflammasome-Mediated Cytokines: A Key Connection between Obesity-Associated NASH and Liver Cancer Progression. Biomedicines 2022; 10(10): 2344 doi: 10.3390/biomedicines10102344
|
| 24 |
Ayumi Eguchi, Sayaka Mizukami, Misato Nakamura, Sousuke Masuda, Hirotada Murayama, Masashi Kawashima, Mari Inohana, Rei Nagahara, Mio Kobayashi, Risako Yamashita, Suzuka Uomoto, Emi Makino, Ryoichi Ohtsuka, Naofumi Takahashi, Shim-Mo Hayashi, Robert R. Maronpot, Makoto Shibutani, Toshinori Yoshida. Metronidazole enhances steatosis-related early-stage hepatocarcinogenesis in high fat diet-fed rats through DNA double-strand breaks and modulation of autophagy. Environmental Science and Pollution Research 2022; 29(1): 779 doi: 10.1007/s11356-021-15689-2
|
| 25 |
Mohamed Badawi, Jihye Kim, Anees Dauki, Dhruvitkumar Sutaria, Tasneem Motiwala, Ryan Reyes, Nissar Wani, Shamalatha Kolli, Jinmai Jiang, Christopher C. Coss, Samson T. Jacob, Mitch A. Phelps, Thomas D. Schmittgen. CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATP-competitive mTOR inhibitor INK128. Oncotarget 2018; 9(40): 26032 doi: 10.18632/oncotarget.25430
|
| 26 |
Shilpa R. Nagarajan, Amanda E. Brandon, Jessie A. McKenna, Harrison C. Shtein, Thinh Q. Nguyen, Eurwin Suryana, Philip Poronnik, Gregory J. Cooney, Darren N. Saunders, Andrew J. Hoy, Manlio Vinciguerra. Insulin and diet-induced changes in the ubiquitin-modified proteome of rat liver. PLOS ONE 2017; 12(3): e0174431 doi: 10.1371/journal.pone.0174431
|
| 27 |
Liang Yu, Fengdan Xu, Lin Gao. Predict New Therapeutic Drugs for Hepatocellular Carcinoma Based on Gene Mutation and Expression. Frontiers in Bioengineering and Biotechnology 2020; 8 doi: 10.3389/fbioe.2020.00008
|
| 28 |
Onne A. H. O. Ronda, Bert J. M. van de Heijning, Alain de Bruin, Rachel E. Thomas, Ingrid Martini, Martijn Koehorst, Albert Gerding, Mirjam H. Koster, Vincent W. Bloks, Angelika Jurdzinski, Niels L. Mulder, Rick Havinga, Eline M. van der Beek, Dirk-Jan Reijngoud, Folkert Kuipers, Henkjan J. Verkade, Michael W. Greene. Spontaneous liver disease in wild-type C57BL/6JOlaHsd mice fed semisynthetic diet. PLOS ONE 2020; 15(9): e0232069 doi: 10.1371/journal.pone.0232069
|
| 29 |
Xiaoliang Gao, Yi Chu, Weijie Wang, Wenjiao Li, Wenyao Zhang, Jiayi Cao, Xin Fu, Hui Liu, Di Chen, Daiming Fan, Yongzhan Nie. Detrimental role of SIX1 in hepatic lipogenesis and fibrosis of non‐alcoholic fatty liver disease. Liver International 2023; 43(7): 1473 doi: 10.1111/liv.15578
|
| 30 |
Sarinya Palakhachane, Yuwaporn Ketkaew, Natthaya Chuaypen, Jitnapa Sirirak, Jutatip Boonsombat, Somsak Ruchirawat, Pisit Tangkijvanich, Apichart Suksamrarn, Panupun Limpachayaporn. Synthesis of sorafenib analogues incorporating a 1,2,3-triazole ring and cytotoxicity towards hepatocellular carcinoma cell lines. Bioorganic Chemistry 2021; 112: 104831 doi: 10.1016/j.bioorg.2021.104831
|
| 31 |
Zhenqiu Liu, Xianhua Mao, Yanfeng Jiang, Ning Cai, Li Jin, Tiejun Zhang, Xingdong Chen. Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China. Cancer Medicine 2019; 8(12): 5787 doi: 10.1002/cam4.2477
|
| 32 |
Xiang‐Kun Wang, Xi‐Wen Liao, Cheng‐Kun Yang, Zheng‐Qian Liu, Quan‐Fa Han, Xin Zhou, Lin‐Bo Zhang, Teng Deng, Yi‐Zhen Gong, Jian‐Lu Huang, Rui Huang, Chuang‐Ye Han, Ting‐Dong Yu, Hao Su, Xin‐Ping Ye, Tao Peng, Guang‐Zhi Zhu. Oncogene PLCE1 may be a diagnostic biomarker and prognostic biomarker by influencing cell cycle, proliferation, migration, and invasion ability in hepatocellular carcinoma cell lines. Journal of Cellular Physiology 2020; 235(10): 7003 doi: 10.1002/jcp.29596
|
| 33 |
Serdar A. Gurses, Sunil Banskar, Cody Stewart, Bill Trimoski, Roman Dziarski, Dipika Gupta. Nod2 protects mice from inflammation and obesity-dependent liver cancer. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77463-7
|
| 34 |
Lindsey Devisscher, Charlotte L. Scott, Sander Lefere, Sarah Raevens, Eliene Bogaerts, Annelies Paridaens, Xavier Verhelst, Anja Geerts, Martin Guilliams, Hans Van Vlierberghe. Non-alcoholic steatohepatitis induces transient changes within the liver macrophage pool. Cellular Immunology 2017; 322: 74 doi: 10.1016/j.cellimm.2017.10.006
|
| 35 |
Shangfu Li, Dan Gao, Yuyang Jiang. Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma. Metabolites 2019; 9(2): 36 doi: 10.3390/metabo9020036
|